The Annals of Internal Medicine released a study this week showing that giving heroin users the overdose antidote naloxone is a cost-effective way to prevent overdose death and save lives.
Phillip Coffin, MD, director of Substance Use Research at the San Francisco Department of Public Health and Assistant Clinical Professor at the University of California San Francisco, and Sean Sullivan, PhD, professor and director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington, co-authored the study.
Drug overdose is now the leading cause of injury death in the United States with opioids, such as heroin, accounting for about 80 percent of those deaths. Naloxone, according to its manufacturers, is a safe and effective antidote that works by temporarily blocking opioid receptors.
As of 2010, 183 public health programs around the country, including those supported by the San Francisco Department of Public Health, had trained more than 53,000 individuals in how to use naloxone. These programs had documented more than 10,000 cases of successful overdose reversals.